UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041363
Receipt number R000047224
Scientific Title Effects of informing 'non-responding women to cancer screening for the last 10 years' on their attitudes to the following screening
Date of disclosure of the study information 2020/08/09
Last modified on 2024/02/13 17:04:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of informing 'non-responding women to cancer screening for the last 10 years' on their attitudes to the following screening

Acronym

Effects of informing 'non-responding women to cancer screening'

Scientific Title

Effects of informing 'non-responding women to cancer screening for the last 10 years' on their attitudes to the following screening

Scientific Title:Acronym

Effects of informing 'non-responding women to cancer screening'

Region

Japan


Condition

Condition

Cancer screening

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To estimate effects of informing non-responding cancer screening for the last 10 years

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cancer screening rate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Informing non-responding women to cancer screening for the last 10 years

Interventions/Control_2

not informing

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

45 years-old <=

Age-upper limit

55 years-old >=

Gender

Female

Key inclusion criteria

Residents in Okazaki city

Key exclusion criteria

none

Target sample size

25000


Research contact person

Name of lead principal investigator

1st name Miki
Middle name
Last name Watanabe

Organization

Nagoya City University Graduate School of Medical Sciences

Division name

Department of Public Health

Zip code

467-8601

Address

1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan

TEL

052-853-8176

Email

mwata911@med.nagoya-cu.ac.jp


Public contact

Name of contact person

1st name Miki
Middle name
Last name Watanabe

Organization

Nagoya City University Graduate School of Medical Sciences

Division name

Department of Public Health

Zip code

467-8601

Address

1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan

TEL

052-853-8176

Homepage URL


Email

mwata911@med.nagoya-cu.ac.jp


Sponsor or person

Institute

Department of Public Health,
Nagoya City University Graduate School of Medical Sciences

Institute

Department

Personal name



Funding Source

Organization

Aichi Cancer Research Foundation

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya City University Graduate School of Medical Sciences and Nagoya City University Hospital Institutional Review Board

Address

1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan

Tel

052-858-7215

Email

clinical_research@med.nagoya-cu.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

60-19-0046

Org. issuing International ID_1

Nagoya City University Graduate School of Medical Sciences and Nagoya City University Hospital Institutional Review Board

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

名古屋市立大学大学院医学研究科(愛知県)、岡崎市保健所(愛知県)


Other administrative information

Date of disclosure of the study information

2020 Year 08 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

2000

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 05 Month 07 Day

Date of IRB

2019 Year 06 Month 17 Day

Anticipated trial start date

2019 Year 06 Month 20 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 08 Month 09 Day

Last modified on

2024 Year 02 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047224


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name